ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Diabetes-Related Alterations in Vectorcardiographic Repolarization Geometry: Insights from Physiological and Machine-Learning Analysis.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond Diabetes Classification: Interpreting Vectorcardiographic Repolarization Geometry as a Cardiometabolic Electrical Phenotype [Letter].Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetes is associated with alterations in cardiac electrophysiology, yet the extent to which metabolic dysfunction influences spatial ventricular repolarization geometry remains unclear. Vectorcardiographic (VCG) analysis provides a spatial representation of cardiac electrical activity and may reveal subtle electrophysiological changes associated with metabolic disease. Methods: This study analyzed VCG features in 200 adults to characterize the relationship between diabetes and depolarization-repolarization dynamics. Spatial parameters including QRS-T angle, T-wave and QRS magnitudes, loop morphology indices, and interval-based features were extracted from reconstructed orthogonal leads derived from standard electrocardiograms. Associations between clinical variables and VCG parameters were evaluated using Pearson correlation analysis and principal component analysis. A Random Forest classifier was used to assess whether VCG features capture metabolic influences, with model performance evaluated on a holdout dataset. Permutation testing assessed statistical significance, and SHAP (Shapley Additive Explanations) analysis was used to quantify feature contributions to model predictions. Results: The Random Forest classifier demonstrated moderate discrimination between participants with and without diabetes (ROC AUC = 0.878; PR AUC = 0.631) with acceptable calibration (Brier score = 0.127), and statistical significance confirmed by permutation testing (p = 0.010). SHAP analysis identified spatial QRS-T angle as the most influential predictor, followed by T-wave magnitude, systolic blood pressure, T-loop area, and body mass index. Repolarization-related VCG features consistently contributed the greatest influence on model predictions. Conclusion: Diabetes is associated with measurable alterations in ventricular repolarization geometry, with spatial QRS-T angle and related VCG parameters emerging as key electrophysiological signatures. These findings suggest that metabolic dysregulation contributes to early electrical remodeling and highlight vectorcardiographic phenotyping as a potential noninvasive approach for investigating cardiometabolic influences on myocardial electrical function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.